DIGIPHARM will bring value-based healthcare to life using blockchain technology. Digipharm aims to utilise innovative blockchain technology to overcome barriers to patient access and innovative pricing, reduce costs for all stakeholders, and bypass infrastructural limitations to drive value improvement, incentivise innovation and expedite the transformation to personalised healthcare. Digipharms’ solutions aim to accelerate the much needed restructuring of healthcare delivery systems to a value-based approach. The inherent flaws of current global healthcare infrastructure result in substantial inefficiency, wastage and sub-optimal health outcomes for the most important stakeholder; the patient. In healthcare today, there is a lack of incentive for health systems and providers to focus on mutually beneficial collaboration and the maximisation of patient outcomes.
Digipharms’ platforms are a decentralised public/private blockchain based solution that enables the delivery of value based pricing agreements to stakeholders and securely gathers and stores real world evidence from patient data. It enables the delivery of personalised healthcare solutions.
Digipharms’ vision is to be ‘the pioneer of value-based healthcare delivery, innovative evidence generation and patient empowerment across the healthcare industry’ using revolutionary blockchain technology.
The Future of Healthcare-
Value Based Care
Healthcare systems around the world are currently threatened by challenges unique to our time; unsustainable expenditure, ageing populations and the increasing prevalence of chronic diseases. The concept of value based healthcare proposes that payment for healthcare should be tied to the quality of care and the benefits it provides; switching from a ‘fee for service’ to a ‘fee for performance’ reimbursement model.
Innovative pricing solutions such as value-based pricing offer an increasingly dynamic solution to address the uncertainty around the cost of treatment relative to patient outcomes. Such mechanisms reward manufacturers and providers for improving patient outcomes, incentivise innovation and encourage the transition to patient centric healthcare.
Pioneering Evidence Generation
Innovative evidence generation solutions are necessary to satisfy the requirement of relevant, timely and quality data to inform the provision of optimised value based healthcare. Circumventing the use of static or retrospective data will open the horizon to superior forecasting, confidence in decision making and global oversight with regards to current developments in an increasingly dynamic industry such as healthcare.
Use of DIGIPHARM Tokens
Digipharm (DPH) tokens will be used to pay license/access fees on Digipharm platforms. Access
fees will invariably be determined and stipulated in USD value and the quantity of tokens
required will depend on the type of access (manufacturer, patient, payer or provider) combined
with the form of interaction required. The quantity of tokens required for such interactions is
subject to change, relative to the market value of DPH.
Charity Foundation= 0.5%
Legal and Regulatory 15%
Professional Services 15.5%
Product Development 65%
Referral/ bounties= 1%
Reserve/ Product Development= 14%
Team / Partners= 20%
DPH token sale Information
DPH Supply: 100,000,000 Fixed (ERC-20)
»» Ticker code: DPH
»» Decimal Places: 18
»» Token Price 1.00 USD
Pre – Sale: 15,000,000 DPH
Pre – Sale Discount: 35%
Base Price: $ 1.00 USD
Pre – Sale Length: 4 Weeks
Main Sale: 50,000,000 DPH
Week 1: 25% Capped at 25 million tokens
Week 2: 15% Capped at 15 million tokens
Week 3: 10% Capped at 10 million tokens
Week 4: 1.00 USD
Unsold tokens will be burnt.
Some Important Links of DIGIPHARM
My Bitcointalk Username= Mungurul
Bitcointalk Profile= https://bitcointalk.org/index.php?action=profile;u=1014315